• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
77,844.52 -114.00
( -0.15%)
Global Indices
Nasdaq
49,922.52 603.26
(1.22%)
Dow Jones
7,387.39 107.17
(1.47%)
Hang Seng
62,916.52 3,403.40
(5.72%)
Nikkei 225
10,288.99 -149.67
(-1.43%)
Forex
USD-INR
95.18 0.09
(0.09%)
EUR-INR
111.29 -0.04
(-0.04%)
GBP-INR
128.89 -0.01
(-0.01%)
JPY-INR
0.60 0.00
(-0.23%)

EQUITY - MARKET SCREENER

Micropro Software Solutions Ltd
Industry :  Computers - Software - Medium / Small
BSE Code
ISIN Demat
Book Value()
75780
INE0PZK01014
32.4543687
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
MICROPRO
0
28.46
EPS(TTM)
Face Value()
Div & Yield %
0
10
0
 

USFDA completes inspection of Enzene's manufacturing unit at Chakan, Pune
Feb 16,2026
Alkem Laboratories announced that the United States Food and Drug Administration (USFDA) has completed a Pre-Approval Inspection (PAI) on 13 February, 2026 at the manufacturing facility of Enzene Biosciences (Enzene), a subsidiary of the Company in India located at Chakan, Pune.

At the conclusion of the inspection, the USFDA issued a Form 483 with 6 procedural observations. Enzene has achieved Zero observations related to data integrity – a critical validation of Enzene's quality systems and the reliability of regulatory filings.

Enzene is in the process of preparing and submitting its response to the USFDA within the stipulated timeline and has initiated appropriate corrective and preventive actions.